Glob Bioenergi
Global Bioenergies SA is in the process of liquidation. Previously, the company was engaged in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. The company was incorporated in 2008 and is headquartered in Évry, France.
Glob Bioenergi (ALGBE) - Net Assets
Latest net assets as of December 2024: €1.69 Million EUR
Based on the latest financial reports, Glob Bioenergi (ALGBE) has net assets worth €1.69 Million EUR as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€9.65 Million) and total liabilities (€7.96 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.69 Million |
| % of Total Assets | 17.54% |
| Annual Growth Rate | 9.5% |
| 5-Year Change | -59.04% |
| 10-Year Change | -78.57% |
| Growth Volatility | 129.74 |
Glob Bioenergi - Net Assets Trend (2008–2024)
This chart illustrates how Glob Bioenergi's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Glob Bioenergi (2008–2024)
The table below shows the annual net assets of Glob Bioenergi from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.69 Million | -83.74% |
| 2023-12-31 | €10.41 Million | +36.06% |
| 2022-12-31 | €7.65 Million | -59.02% |
| 2021-12-31 | €18.66 Million | +351.70% |
| 2020-12-31 | €4.13 Million | -57.44% |
| 2019-12-31 | €9.71 Million | +54.57% |
| 2018-12-31 | €6.28 Million | -54.22% |
| 2017-12-31 | €13.72 Million | +47.58% |
| 2016-12-31 | €9.30 Million | +17.68% |
| 2015-12-31 | €7.90 Million | -55.83% |
| 2014-12-31 | €17.88 Million | -24.77% |
| 2013-12-31 | €23.77 Million | +267.29% |
| 2012-12-31 | €6.47 Million | +63.77% |
| 2011-12-31 | €3.95 Million | -34.71% |
| 2010-12-31 | €6.05 Million | +2144.93% |
| 2009-12-31 | €-296.00K | -174.69% |
| 2008-12-31 | €396.30K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Glob Bioenergi's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 562010600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €908.45K | 53.68% |
| Other Comprehensive Income | €6.64 Million | 392.63% |
| Other Components | €1.00 | 0.00% |
| Total Equity | €1.69 Million | 100.00% |
Glob Bioenergi Competitors by Market Cap
The table below lists competitors of Glob Bioenergi ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Conwest Assoc Part L
PINK:CWPS
|
$288.58K |
|
UNITED NATURAL FDS
BE:UN3
|
$288.65K |
|
DALDRUP&SOEHNE
MU:4DS
|
$288.82K |
|
ARCADIS
MU:HIJ2
|
$289.05K |
|
SCOR SE (SDRC.SG)
STU:SDRC
|
$288.53K |
|
CAREER EDUCATION
MU:CE1
|
$288.46K |
|
Lachish
TA:LHIS
|
$288.32K |
|
CARTER
MU:HCH
|
$288.29K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Glob Bioenergi's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 10,407,177 to 1,692,414, a change of -8,714,763 (-83.7%).
- Net loss of 5,861,000 reduced equity.
- Other comprehensive income decreased equity by 973,904.
- Other factors decreased equity by 1,879,859.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-5.86 Million | -346.31% |
| Other Comprehensive Income | €-973.90K | -57.55% |
| Other Changes | €-1.88 Million | -111.08% |
| Total Change | €- | -83.74% |
Book Value vs Market Value Analysis
This analysis compares Glob Bioenergi's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.20x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.07x to 0.20x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | €0.25 | €0.02 | x |
| 2009-12-31 | €-6.16 | €0.02 | x |
| 2010-12-31 | €3.77 | €0.02 | x |
| 2011-12-31 | €2.35 | €0.02 | x |
| 2012-12-31 | €2.89 | €0.02 | x |
| 2013-12-31 | €8.49 | €0.02 | x |
| 2014-12-31 | €6.43 | €0.02 | x |
| 2015-12-31 | €2.80 | €0.02 | x |
| 2016-12-31 | €2.78 | €0.02 | x |
| 2017-12-31 | €3.06 | €0.02 | x |
| 2018-12-31 | €1.24 | €0.02 | x |
| 2019-12-31 | €1.07 | €0.02 | x |
| 2020-12-31 | €0.40 | €0.02 | x |
| 2021-12-31 | €1.24 | €0.02 | x |
| 2022-12-31 | €0.50 | €0.02 | x |
| 2023-12-31 | €0.58 | €0.02 | x |
| 2024-12-31 | €0.09 | €0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Glob Bioenergi utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -346.31%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1625.06%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 5.70x
- Recent ROE (-346.31%) is below the historical average (-106.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -60.79% | 0.00% | 0.00x | 1.32x | €-280.52K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | €-1.27 Million |
| 2010 | -26.14% | -703.11% | 0.03x | 1.13x | €-2.19 Million |
| 2011 | -88.69% | -1238.52% | 0.05x | 1.47x | €-3.90 Million |
| 2012 | 41.46% | 113.41% | 0.25x | 1.44x | €2.04 Million |
| 2013 | -21.59% | -443.33% | 0.04x | 1.11x | €-7.51 Million |
| 2014 | -34.98% | -348.91% | 0.07x | 1.34x | €-8.04 Million |
| 2015 | -131.60% | -762.37% | 0.06x | 2.81x | €-11.18 Million |
| 2016 | -114.11% | -1977.82% | 0.02x | 2.75x | €-11.54 Million |
| 2017 | -103.90% | -4653.29% | 0.01x | 2.25x | €-15.62 Million |
| 2018 | -217.13% | -1970.50% | 0.03x | 4.05x | €-14.26 Million |
| 2019 | -134.19% | -10846.34% | 0.00x | 2.94x | €-13.69 Million |
| 2020 | -272.62% | -17461.05% | 0.00x | 6.31x | €-11.56 Million |
| 2021 | -63.08% | -11663.96% | 0.00x | 1.70x | €-13.64 Million |
| 2022 | -156.71% | -1718.39% | 0.03x | 2.82x | €-12.75 Million |
| 2023 | -83.18% | -266.41% | 0.18x | 1.75x | €-9.70 Million |
| 2024 | -346.31% | -1625.06% | 0.04x | 5.70x | €-6.03 Million |
Industry Comparison
This section compares Glob Bioenergi's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $2,336,888,510
- Average return on equity (ROE) among peers: -4.77%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Glob Bioenergi (ALGBE) | €1.69 Million | -60.79% | 4.70x | $288.57K |
| Air Liquide SA (AI) | $19.00 Billion | 12.81% | 1.21x | $99.38 Billion |
| Arkema SA (AKE) | $1.81 Billion | -9.49% | 1.18x | $3.23 Billion |
| Afyren SAS (ALAFY) | $61.80 Million | -15.51% | 0.14x | $1.77 Million |
| Carbios (ALCRB) | $13.06 Million | -16.92% | 0.05x | $126.57 Million |
| Encres Dubuit SA (ALDUB) | $19.30 Million | -6.18% | 0.26x | $2.55 Million |
| Berkem Group SA (ALKEM) | $-163.00K | 0.00% | 0.00x | $10.44 Million |
| Plásticos Compuestos, S.A. (ALKOM) | $14.81 Million | -2.48% | 1.80x | $1.32 Million |
| Vinpai SAS (ALVIN) | $2.54 Million | 0.16% | 2.31x | $2.09 Million |
| EPC Groupe (EXPL) | $103.05 Million | -5.37% | 2.38x | $139.39 Million |